Journal Mobile Options
Table of Contents
Vol. 17, No. 6, 2008
Issue release date: October 2008
Section title: Original Paper
Open Access Gateway
Med Princ Pract 2008;17:447–452

Technetium-99m-Labelled Sulesomab (LeukoScan) in the Evaluation of Soft Tissue Infections

Quigley A.-M. · Gnanasegaran G. · Buscombe J.R. · Hilson A.J.W.
Department of Nuclear Medicine, Royal Free Hospital, London, UK
email Corresponding Author

Dr. J.R. Buscombe

Nuclear Medicine Department, Royal Free Hospital

Pond Street

London NW3 2QG (UK)

Tel. +44 20 7830 2470, Fax +44 20 7472 6202, E-Mail


  1. Ryan PJ: Leukoscan for orthopaedic imaging in clinical practice. Nucl Med Commun 2002;23:707–714.
  2. Skehan SJ, White JF, Evans JW, Parry-Jones DR, Solanki CK, Ballinger JR, Chilvers ER, Peters AM: Mechanism of accumulation of 99mTc-sulesomab in inflammation. J Nucl Med 2003;44:11–18.
  3. Becker W: Bone and soft tissue; in Cox PH, Buscombe JR (eds): The Imaging of Infection and Inflammation. Amsterdam, Kluwer, 1998, pp 199–217.
  4. Hakki S, Harwood SJ, Morissey MA, Camblin JG, Laven DL, Webster WB: Comparative study of monoclonal antibody scan in diagnosing orthopaedic infection. Clin Orthop 1997;335:275–285.
  5. Annovazzi AA, Bagni BB, Burroni LC, D’Alessandria CA, Signore AA: Nuclear medicine imaging of inflammatory/infective disorders of the abdomen. Nucl Med Commun 2005;26:657–664.
  6. Love C, Tronco GG, Palestro CJ: Imaging of infection and inflammation with 99mTc-fanolesomab. Q J Nucl Med Mol Imaging 2006;50:113–120.
  7. Sciuk J, Brandau W, Vollet B, Stucker R, Erlemann R, Bartenstein P, Peters PE, Schober O: Comparison of technetium-99m polyclonal human immunoglobulin and technetium-99m monoclonal antibodies for imaging chronic osteomyelitis: first clinical results. Eur J Nucl Med 1991;18:401–407.
  8. Shanthly N, Aruva MR, Zhang K, Mathew B, Thakur ML: 99mTc-Fanolesomab: affinity, pharmacokinetics and preliminary evaluation. Q J Nucl Med Mol Imaging 2006;50:104–112.